Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

FDA's elevated meeting status signals transition from biomarker data discussions to Accelerated Approval discussions OS ...

Rhythm Biosciences is entering a new commercial era, following the first sale of its revolutionary Colostat bowel cancer ...

Leerink Global Healthcare Conference 2026 March 10, 2026 11:20 AM EDTCompany ParticipantsScott Reents - Executive VP & ...

WVU Medicine St. Joseph’s Hospital and the Rotary Club of Buckhannon Upshur are offering affordable spring community blood screenings in Rock Cave (March 28) and Buckhannon (April 11, 18, 25 and May 2 ...

Broccoli shots may improve athletic performance and recovery by reducing muscle damage and inflammation, but more research is needed. Sulforaphane, a bioactive plant compound in broccoli, is ...

Long viewed as a store of value, gold makes for a strategic asset in investment portfolios. According to the “Gold as a ...

Consumer Staples ended the day lower, while Tech once again emerged as the strongest sector (+1.9%). Within the Tech space, Life360 rallied 10.3% on news that it has now been added to the US S&P Small ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

Cancer remains a leading health challenge in the U.S., but lifestyle choices — especially diet — can play a role in lowering the risk. Cancer prevention isn’t about one “superfood,” said Dr. André Goy ...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...